Christopher Hager

2.1k total citations · 2 hit papers
24 papers, 1.3k citations indexed

About

Christopher Hager is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Christopher Hager has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 10 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Christopher Hager's work include Antifungal resistance and susceptibility (9 papers), Probiotics and Fermented Foods (8 papers) and Gut microbiota and health (7 papers). Christopher Hager is often cited by papers focused on Antifungal resistance and susceptibility (9 papers), Probiotics and Fermented Foods (8 papers) and Gut microbiota and health (7 papers). Christopher Hager collaborates with scholars based in United States, Switzerland and Austria. Christopher Hager's co-authors include Mahmoud A. Ghannoum, Lisa Long, Emily L. Larkin, Pranab K. Mukherjee, N. Isham, Jyotsna Chandra, Mauricio Retuerto, Katyna Borroto–Esoda, Mahmoud Ghannoum and Gautier Hoarau and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Christopher Hager

24 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn’s Disease

2016 342 citations Gautier Hoarau, Pranab K. Mukherjee et al. mBio profile →
The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation

2017 316 citations Emily L. Larkin, Christopher Hager et al. Antimicrobial Agents and Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Hager United States	14	749	558	518	220	127	24	1.3k
Samir Jawhara France	21	703 0.9×	586 1.1×	326 0.6×	285 1.3×	146 1.1×	45	1.4k
Judith Behnsen United States	15	538 0.7×	715 1.3×	265 0.5×	342 1.6×	130 1.0×	25	1.6k
Selene Mogavero Germany	21	898 1.2×	501 0.9×	663 1.3×	204 0.9×	24 0.2×	38	1.5k
Sarah Jégou France	8	478 0.6×	1.0k 1.8×	294 0.6×	253 1.1×	285 2.2×	9	1.4k
Mauricio Retuerto United States	13	467 0.6×	416 0.7×	355 0.7×	127 0.6×	51 0.4×	31	1.1k
Stefano Perito Italy	29	1.0k 1.4×	422 0.8×	1.0k 1.9×	201 0.9×	35 0.3×	66	2.0k
Jessica Galloway-Peña United States	22	554 0.7×	590 1.1×	290 0.6×	109 0.5×	53 0.4×	43	1.3k
Emily Fontana United States	11	508 0.7×	830 1.5×	213 0.4×	274 1.2×	67 0.5×	18	1.3k
Simone Becattini United States	15	504 0.7×	768 1.4×	299 0.6×	237 1.1×	83 0.7×	24	1.6k
Marc Swidergall United States	21	902 1.2×	334 0.6×	578 1.1×	134 0.6×	23 0.2×	31	1.3k

Countries citing papers authored by Christopher Hager

Since Specialization

Citations

This map shows the geographic impact of Christopher Hager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Hager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Hager more than expected).

Fields of papers citing papers by Christopher Hager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Hager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Hager. The network helps show where Christopher Hager may publish in the future.

Co-authorship network of co-authors of Christopher Hager

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Hager. A scholar is included among the top collaborators of Christopher Hager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Hager. Christopher Hager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gampenrieder, Simon Peter, Gabriel Rinnerthaler, Christoph Tinchon, et al.. (2022). Abstract P1-21-08: Brain metastases (BM) from breast cancer: Real-word data from the Austrian AGMT_MBC-registry. Cancer Research. 82(4_Supplement). P1–21. 1 indexed citations

Martino, Luca Di, Carlo De Salvo, Christopher Hager, et al.. (2021). Candida tropicalis Infection Modulates the Gut Microbiome and Confers Enhanced Susceptibility to Colitis in Mice. Cellular and Molecular Gastroenterology and Hepatology. 13(3). 901–923. 16 indexed citations

Gampenrieder, Simon Peter, Gabriel Rinnerthaler, Christoph Tinchon, et al.. (2021). Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry. Breast Cancer Research. 23(1). 112–112. 94 indexed citations

Buttó, Ludovica F., Shyam K. More, Nan Zhao, et al.. (2020). Intestinal Stem Cell Niche Defects Result in Impaired 3D Organoid Formation in Mouse Models of Crohn's Disease-like Ileitis. Stem Cell Reports. 15(2). 389–407. 12 indexed citations

Miyagi, Masaru, Daisuke Saigusa, Christopher Hager, et al.. (2020). Indole-3-acetic acid synthesized through the indole-3-pyruvate pathway promotes Candida tropicalis biofilm formation. PLoS ONE. 15(12). e0244246–e0244246. 8 indexed citations

Hager, Christopher, N. Isham, Jyotsna Chandra, et al.. (2019). Effects of a Novel Probiotic Combination on Pathogenic Bacterial-Fungal Polymicrobial Biofilms. mBio. 10(2). 62 indexed citations

Ghannoum, Mahmoud A., L. Long, N. Isham, et al.. (2019). Activity of a Novel 1,3-Beta- d -Glucan Synthase Inhibitor, Ibrexafungerp (Formerly SCY-078), against Candida glabrata. Antimicrobial Agents and Chemotherapy. 63(12). 24 indexed citations

Retuerto, Mauricio, Christopher Hager, Lingpeng Shan, et al.. (2019). Fungal Translocation Is Associated with Immune Activation and Systemic Inflammation in Treated HIV. AIDS Research and Human Retroviruses. 35(5). 461–472. 24 indexed citations

Ghannoum, Mahmoud A., et al.. (2019). The Probiotic BIOHM Improves Nutrient Absorption by Disrupting Gastrointestinal Biofilms. 7(2). 4 indexed citations

10.

Hager, Christopher, Emily L. Larkin, Lisa Long, & Mahmoud A. Ghannoum. (2018). Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model. Journal of Antimicrobial Chemotherapy. 73(8). 2085–2088. 79 indexed citations

11.

Larkin, Emily L., Christopher Hager, Jyotsna Chandra, et al.. (2017). The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. Antimicrobial Agents and Chemotherapy. 61(5). 316 indexed citations breakdown →

12.

Hager, Christopher & Mahmoud A. Ghannoum. (2017). The mycobiome in HIV. Current Opinion in HIV and AIDS. 13(1). 69–72. 27 indexed citations

13.

Hager, Christopher & Mahmoud A. Ghannoum. (2017). The mycobiome: Role in health and disease, and as a potential probiotic target in gastrointestinal disease. Digestive and Liver Disease. 49(11). 1171–1176. 70 indexed citations

14.

Larkin, Emily L., Lisa Long, Christopher Hager, Karen Joy Shaw, & Mahmoud Ghannoum. (2017). Evaluation of the In Vitro and In Vivo Antifungal Activity of APX001A/APX001 Against Candida auris. Open Forum Infectious Diseases. 4(suppl_1). S471–S472. 5 indexed citations

15.

Mofidfar, Mohammad, Jia Wang, Lisa Long, et al.. (2016). Polymeric Nanofiber/Antifungal Formulations Using a Novel Co-extrusion Approach. AAPS PharmSciTech. 18(6). 1917–1924. 17 indexed citations

16.

Rodriguez‐Palacios, Alexander, Mauricio Retuerto, Christopher Hager, et al.. (2016). Clinical Effects of Gamma-Radiation-ResistantAspergillus sydowiion Germ-Free Mice Immunologically Prone to Inflammatory Bowel Disease. SHILAP Revista de lepidopterología. 2016. 1–7. 5 indexed citations

17.

Hoarau, Gautier, Pranab K. Mukherjee, Corinne Gower‐Rousseau, et al.. (2016). Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn’s Disease. mBio. 7(5). 342 indexed citations breakdown →

18.

Thomas, David R., et al.. (2008). Systemic inflammatory markers in older persons: the effect of oral nutritional supplementation with prebiotics.. PubMed. 11(6). 475–9. 76 indexed citations

19.

Rochat, Florence, et al.. (2005). EFFECT OF A FORMULA WITH ADAPTED PROTEIN PROFILE ON INTESTINAL MICROBIOTA AND GROWTH OF INFANTS. Journal of Pediatric Gastroenterology and Nutrition. 41(4). 508–508. 1 indexed citations

20.

Morrow, Monica, Christopher Hager, David S. Berger, & Bozidar Djordjevic. (1989). Chloroquine as a hyperthermia potentiator. Journal of Surgical Research. 46(6). 637–639. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact